(Q48229577)

English

The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.

scientific article published on 15 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

1 reference

based on heuristic

inferred from title

bipolar disorder

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

object named as

Monsheel Sodhi

2

0 references

author name string

Stefania Bonaccorso

1

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Jiang Li

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

William V Bobo

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Yuejin Chen

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Mevhibe Tumuklu

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Christos Theleritis

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Karuna Jayathilake

8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Herbert Y Meltzer

9

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

publication date

15 April 2015

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Bipolar Disorders

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

17

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

528-535

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Bipolar disorder and metabolic syndrome: an international perspective

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Metabolic syndrome and bipolar disorder: what should psychiatrists know?

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

The metabolic syndrome and schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Atypical antipsychotics related metabolic syndrome in bipolar patients.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Insulin resistance: the link between obesity and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Physiology of the neurotrophins

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Molecular and neural bases underlying roles of BDNF in the control of body weight

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Control of hyperphagia prevents obesity in BDNF heterozygous mice

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Reversal of Behavioral and Metabolic Abnormalities, and Insulin Resistance Syndrome, by Dietary Restriction in Mice Deficient in Brain-Derived Neurotrophic Factor

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Food restriction leads to binge eating dependent upon the effect of the brain-derived neurotrophic factor Val66Met polymorphism.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Association between the brain-derived neurotrophic factor 196G/A polymorphism and eating disorders

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

BDNF regulates eating behavior and locomotor activity in mice

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Susceptibility genes for the side effect of antipsychotics on body weight and obesity

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Fatty Acid desaturase gene polymorphisms and metabolic measures in schizophrenia and bipolar patients taking antipsychotics.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12294

21 January 2018

Identifiers

10.1111/BDI.12294

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

release_rb3snbvaurfprjccjqgvr5hvte

0 references

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25874530

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48229577&oldid=1539410363"